MEP31908A - Peptide compound with biological activity, its preparation and its application - Google Patents

Peptide compound with biological activity, its preparation and its application

Info

Publication number
MEP31908A
MEP31908A MEP-319/08A MEP31908A MEP31908A ME P31908 A MEP31908 A ME P31908A ME P31908 A MEP31908 A ME P31908A ME P31908 A MEP31908 A ME P31908A
Authority
ME
Montenegro
Prior art keywords
preparation
application
biological activity
peptide compound
peptide
Prior art date
Application number
MEP-319/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Philippe Bressollier
Maria Attilia Brugo
Pascale Robineau
Jean-Marie Schmitter
Maurice Sofeir
Maria Camino Urdaci
Bernard Verneuil
Original Assignee
Sanofi Aventis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38481126&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP31908(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis Spa filed Critical Sanofi Aventis Spa
Publication of MEP31908A publication Critical patent/MEP31908A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MEP-319/08A 2006-04-06 2007-04-06 Peptide compound with biological activity, its preparation and its application MEP31908A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000678A ITMI20060678A1 (it) 2006-04-06 2006-04-06 Composto peptidico ad attivita' b iologica sua preparazione e sue applicazioni
PCT/IB2007/002003 WO2007113691A2 (en) 2006-04-06 2007-04-06 Peptide compound with biological activity, its preparation and its application

Publications (1)

Publication Number Publication Date
MEP31908A true MEP31908A (en) 2010-10-10

Family

ID=38481126

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-319/08A MEP31908A (en) 2006-04-06 2007-04-06 Peptide compound with biological activity, its preparation and its application
MEP-2008-319A ME00194B (me) 2006-04-06 2007-04-06 Peptidno jedinjenje biološke aktivnosti, njegovo dobijanje i njegova primjena

Family Applications After (1)

Application Number Title Priority Date Filing Date
MEP-2008-319A ME00194B (me) 2006-04-06 2007-04-06 Peptidno jedinjenje biološke aktivnosti, njegovo dobijanje i njegova primjena

Country Status (35)

Country Link
US (1) US8691773B2 (xx)
EP (1) EP2013234B1 (xx)
JP (1) JP5196407B2 (xx)
KR (1) KR101556414B1 (xx)
CN (1) CN101415725B (xx)
AR (1) AR060350A1 (xx)
AT (1) ATE535540T1 (xx)
AU (1) AU2007232210B2 (xx)
BR (1) BRPI0710846A2 (xx)
CA (1) CA2646892C (xx)
CL (1) CL2007000955A1 (xx)
CR (1) CR10302A (xx)
DO (1) DOP2007000065A (xx)
EA (1) EA015943B1 (xx)
EC (1) ECSP088785A (xx)
GE (1) GEP20115282B (xx)
GT (1) GT200800204A (xx)
HK (1) HK1128480A1 (xx)
HN (1) HN2008001516A (xx)
IL (1) IL194325A (xx)
IT (1) ITMI20060678A1 (xx)
JO (1) JO2739B1 (xx)
MA (1) MA30465B1 (xx)
ME (2) MEP31908A (xx)
MX (1) MX2008012730A (xx)
MY (1) MY151092A (xx)
NI (1) NI200800265A (xx)
NO (1) NO341813B1 (xx)
NZ (1) NZ571477A (xx)
PE (1) PE20080351A1 (xx)
TN (1) TNSN08377A1 (xx)
TW (1) TWI380994B (xx)
UA (1) UA92793C2 (xx)
WO (1) WO2007113691A2 (xx)
ZA (1) ZA200808328B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU92906B1 (en) 2015-12-14 2017-06-20 Luxembourg Inst Science & Tech List Method for enzymatically modifying the tri-dimensional structure of a protein
CN106366168B (zh) * 2016-08-26 2020-09-15 上海交通大学 羊毛硫肽类抗菌肽及其脱氢衍生物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0833657B1 (en) * 1995-06-23 2003-08-27 AMBI Inc. A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection
US5985823A (en) * 1997-06-09 1999-11-16 Ambi Inc. Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
US5932469A (en) * 1997-06-10 1999-08-03 University Of Florida Antimicrobial polypeptide, nucleic acid, and methods of use
ITMI20021800A1 (it) * 2002-08-07 2004-02-08 Proge Farm Srl Composizione farmaceutica e/o nutraceutica comprendente una associazione di microorganismi probiotici non sporigeni e spore di bacillus subtilis e/o clausii.
CA2404356A1 (en) * 2002-09-18 2004-03-18 Canadian Inovatech Inc. Gram-positive antibacterial composition and method for use
US7354888B2 (en) * 2004-11-10 2008-04-08 Danisco A/S Antibacterial composition and methods thereof comprising a ternary builder mixture

Also Published As

Publication number Publication date
ME00194B (me) 2010-10-10
IL194325A (en) 2011-09-27
EA200870414A1 (ru) 2009-02-27
EP2013234A2 (en) 2009-01-14
US20090312262A1 (en) 2009-12-17
NO341813B1 (no) 2018-01-29
AU2007232210A1 (en) 2007-10-11
CR10302A (es) 2009-01-27
TNSN08377A1 (en) 2009-12-29
JP2009532456A (ja) 2009-09-10
MA30465B1 (fr) 2009-06-01
ZA200808328B (en) 2009-12-30
IL194325A0 (en) 2011-08-01
WO2007113691A2 (en) 2007-10-11
PE20080351A1 (es) 2008-06-12
BRPI0710846A2 (pt) 2011-08-23
TWI380994B (zh) 2013-01-01
AU2007232210B2 (en) 2012-11-15
ECSP088785A (es) 2009-01-30
CA2646892A1 (en) 2007-10-11
NO20084671L (no) 2008-11-05
MY151092A (en) 2014-04-15
TW200806688A (en) 2008-02-01
ITMI20060678A1 (it) 2007-10-07
KR101556414B1 (ko) 2015-10-01
CL2007000955A1 (es) 2008-01-18
KR20080110774A (ko) 2008-12-19
NZ571477A (en) 2011-09-30
GEP20115282B (en) 2011-09-12
EP2013234B1 (en) 2011-11-30
JO2739B1 (en) 2014-03-15
NI200800265A (es) 2011-01-10
WO2007113691A3 (en) 2007-12-27
GT200800204A (es) 2010-04-05
DOP2007000065A (es) 2007-11-30
EA015943B1 (ru) 2011-12-30
CN101415725A (zh) 2009-04-22
ATE535540T1 (de) 2011-12-15
HK1128480A1 (en) 2009-10-30
MX2008012730A (es) 2008-11-27
CA2646892C (en) 2016-01-05
UA92793C2 (ru) 2010-12-10
CN101415725B (zh) 2013-08-14
US8691773B2 (en) 2014-04-08
AR060350A1 (es) 2008-06-11
JP5196407B2 (ja) 2013-05-15
HN2008001516A (es) 2011-02-16

Similar Documents

Publication Publication Date Title
CR8112A (es) Composiciones antisepticas, metodos y sistemas
WO2007141278A3 (en) Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof
ATE488232T1 (de) P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen
WO2007141274A3 (en) Human binding molecules having killing activity against staphylococci and uses thereof
BR112012014082A2 (pt) composições e métodos que compreendem variantes de protease
UA94221C2 (xx) Білок ліпокалін$белок липокалин
DE602008000754D1 (de) Tropanverbindungen
WO2009077471A3 (de) Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
CL2008003712A1 (es) Compuestos derivados de tiadiazololoxifenilamidina o tiazoliloxifenilamidina; su procedimiento de preparacion; uso y procedimiento para combatir microorganismos no deseados; agente que comprende a dichos compuestos; compuestos intermediarios; y su procedimiento de preparacion.
TN2010000074A1 (en) Cyclic depsipeptides
WO2007144057A3 (en) Antimicrobial carbon
MX341064B (es) Variantes de la familia il-1.
EA200900261A1 (ru) Применение эсцина
WO2008081682A1 (ja) クリップ
ATE524488T1 (de) Lysobactinamide
SE0801639L (sv) Antimikrobiell sammansättning
MEP31908A (en) Peptide compound with biological activity, its preparation and its application
MY150196A (en) Rumc peptides with antimicrobial activity
ATE474582T1 (de) Pharmazeutische zusammensetzung enthaltend glucan aus mikroalgen
ATE437624T1 (de) Topische zusammensetzungen
EA200870565A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламидобензазепины, их получение, содержащие их композиции и применение
FR2902101B1 (fr) Peptides a activite anti-proliferative
MX2010004690A (es) Compuesto polipeptidico.
UY30259A1 (es) Compuesto peptidico de actividad biologica, su preparacion y sus aplicaciones
RU2011136591A (ru) Антибактериальный и/или противогрибковый компонент, обладающий свойством специфически связываться с бактериями и/или грибами